Clinical Trial Update: IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients

View source ↗

Summary

A clinical trial update reporting on the frequency of IDH1 and IDH2 mutations in patients with acute myeloid leukemia; no trial status or results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Hospital General de Mexico | Conditions: Acute Myeloid Leukemia (AML) | Status: UNKNOWN